Pharma

"Data is the heart of the business, whereas documents are the “packaging” with the intent to create the context of the data in the associated processes"

7 minutes of reading / / By

In December 2020 Forrester published a report that strongly confirmed our thoughts, and the developments we see in our market(s): The Future Of Documents: A Look Beyond The Paradigm Of Paper And Into Opportunities For Innovation – Forrester 2020. Based upon this report, we’ve interviewed thought leaders about the future of documents. In this article, […]

"Data is the heart of the business, whereas documents are the “packaging” with the intent to create the context of the data in the associated processes" Read More »

Structured content: Life Sciences vs. other industries

3 minutes of reading / / By

During the 2019 AMPLEXOR ‘Be The Expert’ meeting, we had the pleasure to present our views on the potential of structured content authoring for the Life Sciences industry. We did so by comparing the adoption of ‘structured content’ in Life Sciences with the state of adoption in other industries. We notably compared Life Sciences with

Structured content: Life Sciences vs. other industries Read More »

IDMP and the need for structured authoring

3 minutes of reading / / By

How FontoXML helps pharmaceutical companies comply with future legislation In Pharma and Life Sciences structured content, or rather structured data, is a hot topic. Most, if not all companies in this industry are in the process of undertaking a multi-year cross-functional program to enable sustainable compliance with the upcoming IDMP requirements and to improve regulatory

IDMP and the need for structured authoring Read More »

Scroll to Top